High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$3.0M
$2,964,483
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
RARE
S
Ultragenyx Pharmaceutical Inc.
Parschauer Karah Herdman
• Officer • EVP and Chief Legal Officer
Discretionary Sell
2026-03-10
$79,526
|
||||||
| RARE |
Ultragenyx Pharmaceutical Inc.
|
Officer • EVP and Chief Legal Officer
Discretionary Sell
|
2026-03-10 | $79,526 | S | Form 4 |
|
RARE
S
Ultragenyx Pharmaceutical Inc.
Parschauer Karah Herdman
• Officer • EVP and Chief Legal Officer
Discretionary Sell
2026-03-06
$128,785
|
||||||
| RARE |
Ultragenyx Pharmaceutical Inc.
|
Officer • EVP and Chief Legal Officer
Discretionary Sell
|
2026-03-06 | $128,785 | S | Form 4 |
| RARE |
Ultragenyx Pharmaceutical Inc.
|
CFO
10b5-1 Sell
|
2026-03-03 | $36,624 | S | Form 4 |
|
RARE
S
Ultragenyx Pharmaceutical Inc.
Crombez Eric
• Officer • EVP and Chief Medical Officer
Sell to Cover
2026-03-02
$160,261
|
||||||
| RARE |
Ultragenyx Pharmaceutical Inc.
|
Officer • EVP and Chief Medical Officer
Sell to Cover
|
2026-03-02 | $160,261 | S | Form 4 |
|
RARE
S
Ultragenyx Pharmaceutical Inc.
Harris Erik
• Officer • EVP & Chief Commercial Officer
Sell to CoverΔOwn -10.5%
2026-03-02
$240,289
|
||||||
| RARE |
Ultragenyx Pharmaceutical Inc.
|
Officer • EVP & Chief Commercial Officer
Sell to CoverΔOwn -10.5%
|
2026-03-02 | $240,289 | S | Form 4 |
| RARE |
Ultragenyx Pharmaceutical Inc.
|
CFO
Sell to Cover
|
2026-03-02 | $190,914x2 | S | Form 4 |
|
RARE
S
Ultragenyx Pharmaceutical Inc.
Huizenga Theodore Alan
• Officer • SVP, Chief Accounting Officer
Sell to Cover
2026-03-02
$37,210
|
||||||
| RARE |
Ultragenyx Pharmaceutical Inc.
|
Officer • SVP, Chief Accounting Officer
Sell to Cover
|
2026-03-02 | $37,210 | S | Form 4 |
| RARE |
Ultragenyx Pharmaceutical Inc.
|
CEO
Sell to Cover
|
2026-03-02 | $1,240,411Large | S | Form 4 |
|
RARE
S
Ultragenyx Pharmaceutical Inc.
Parschauer Karah Herdman
• Officer • EVP and Chief Legal Officer
Sell to Cover
2026-03-02
$185,478
|
||||||
| RARE |
Ultragenyx Pharmaceutical Inc.
|
Officer • EVP and Chief Legal Officer
Sell to Cover
|
2026-03-02 | $185,478 | S | Form 4 |
|
RARE
S
Ultragenyx Pharmaceutical Inc.
Pinion John Richard
• Officer • See Remarks
Sell to Cover
2026-03-02
$228,661
|
||||||
| RARE |
Ultragenyx Pharmaceutical Inc.
|
Officer • See Remarks
Sell to Cover
|
2026-03-02 | $228,661 | S | Form 4 |
| RARE |
Ultragenyx Pharmaceutical Inc.
|
CFO
10b5-1 Sell
|
2026-02-02 | $72,117 | S | Form 4 |
| RARE |
Ultragenyx Pharmaceutical Inc.
|
CFO
10b5-1 Sell
|
2025-12-10 | $112,087 | S | Form 4 |
| RARE |
Ultragenyx Pharmaceutical Inc.
|
CFO
Sell to Cover
|
2025-10-13 | $250,252 | S | Form 4 |
|
RARE
S
Ultragenyx Pharmaceutical Inc.
Huizenga Theodore Alan
• Officer • SVP, Chief Accounting Officer
Sell to Cover
2025-09-18
$1,867
|
||||||
| RARE |
Ultragenyx Pharmaceutical Inc.
|
Officer • SVP, Chief Accounting Officer
Sell to Cover
|
2025-09-18 | $1,867 | S | Form 4 |